Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
174.00
+1.00 (0.58%)
Apr 2, 2025, 10:45 AM CST

Lumosa Therapeutics Statistics

Total Valuation

TPEX:6535 has a market cap or net worth of TWD 29.22 billion. The enterprise value is 27.89 billion.

Market Cap 29.22B
Enterprise Value 27.89B

Important Dates

The last earnings date was Tuesday, March 4, 2025.

Earnings Date Mar 4, 2025
Ex-Dividend Date n/a

Share Statistics

TPEX:6535 has 168.90 million shares outstanding. The number of shares has increased by 0.64% in one year.

Current Share Class n/a
Shares Outstanding 168.90M
Shares Change (YoY) +0.64%
Shares Change (QoQ) +2.55%
Owned by Insiders (%) 1.62%
Owned by Institutions (%) 6.44%
Float 89.41M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 15.28
P/TBV Ratio 15.29
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -65.66
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -93.98

Financial Position

The company has a current ratio of 7.64, with a Debt / Equity ratio of 0.00.

Current Ratio 7.64
Quick Ratio 6.92
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.03
Interest Coverage -1,909.73

Financial Efficiency

Return on equity (ROE) is -26.03% and return on invested capital (ROIC) is -13.22%.

Return on Equity (ROE) -26.03%
Return on Assets (ROA) -11.78%
Return on Invested Capital (ROIC) -13.22%
Return on Capital Employed (ROCE) -18.49%
Revenue Per Employee 910,558
Profits Per Employee -9.88M
Employee Count 43
Asset Turnover 0.02
Inventory Turnover 0.21

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -2.59% in the last 52 weeks. The beta is 0.42, so TPEX:6535's price volatility has been lower than the market average.

Beta (5Y) 0.42
52-Week Price Change -2.59%
50-Day Moving Average 227.39
200-Day Moving Average 251.99
Relative Strength Index (RSI) 22.85
Average Volume (20 Days) 306,166

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:6535 had revenue of TWD 39.15 million and -424.78 million in losses. Loss per share was -2.60.

Revenue 39.15M
Gross Profit 17.71M
Operating Income -357.12M
Pretax Income -436.84M
Net Income -424.78M
EBITDA -353.03M
EBIT -357.12M
Loss Per Share -2.60
Full Income Statement

Balance Sheet

The company has 1.35 billion in cash and 8.48 million in debt, giving a net cash position of 1.34 billion or 7.96 per share.

Cash & Cash Equivalents 1.35B
Total Debt 8.48M
Net Cash 1.34B
Net Cash Per Share 7.96
Equity (Book Value) 1.93B
Book Value Per Share 11.32
Working Capital 1.34B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -296.33 million and capital expenditures -450,000, giving a free cash flow of -296.78 million.

Operating Cash Flow -296.33M
Capital Expenditures -450,000
Free Cash Flow -296.78M
FCF Per Share -1.76
Full Cash Flow Statement

Margins

Gross Margin 45.24%
Operating Margin -912.09%
Pretax Margin -1,115.69%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TPEX:6535 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.64%
Shareholder Yield -0.64%
Earnings Yield -1.45%
FCF Yield -1.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TPEX:6535 has an Altman Z-Score of 104.22.

Altman Z-Score 104.22
Piotroski F-Score n/a